Literature DB >> 34346124

Curcumol inhibits ferritinophagy to restrain hepatocyte senescence through YAP/NCOA4 in non-alcoholic fatty liver disease.

Xiaoyu Qi1, Anping Song1, Mingyue Ma1, Peipei Wang1, Xinbei Zhang1, Chunfeng Lu2, Junxiu Zhang1, Shuguo Zheng1, Huanhuan Jin1.   

Abstract

OBJECTIVES: In recent years, cellular senescence has attracted a lot of interest in researchers due to its involvement in non-alcoholic fatty liver disease (NAFLD). However, the mechanism of cellular senescence is not clear. The purpose of this study was to investigate the effect of curcumol on hepatocyte senescence in NAFLD and the molecular mechanisms implicated.
MATERIALS AND METHODS: LVG Golden Syrian hamsters, C57BL/6J mice and human hepatocyte cell line LO2 were used. Cellular senescence was assessed by analyses of senescence marker SA-β-gal, p16 and p21, H3K9me3, γ-H2AX and telomerase activity.
RESULTS: The results showed that curcumol could inhibit hepatocyte senescence in both in vivo and in vitro NAFLD models, and the mechanism might be related to its regulation of ferritinophagy and subsequent alleviation of iron overload. Moreover, overexpression of nuclear receptor coactivator 4 (NCOA4) weakened the effect of curcumol on ferritinophagy-mediated iron overload and cellular senescence. Furthermore, we demonstrated that curcumol reduced the expression of NCOA4 by Yes-associated protein (YAP). In addition, depression of YAP could impair the effect of curcumol on iron overload and cellular senescence.
CONCLUSION: Our results clarified the mechanism of curcumol inhibition of hepatocyte senescence through YAP/NCOA4 regulation of ferritinophagy in NAFLD. These findings provided a promising option of curcumol to regulate cellular senescence by target YAP/NCOA4 for the treatment of NAFLD.
© 2021 The Authors. Cell Proliferation published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Yes-associated protein; cellular senescence; curcumol; ferritinophagy; iron overload; non-alcoholic fatty liver disease; nuclear receptor coactivator 4

Year:  2021        PMID: 34346124     DOI: 10.1111/cpr.13107

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  4 in total

Review 1.  Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease.

Authors:  Johanna Pedroza-Diaz; Johanna C Arroyave-Ospina; Sandra Serna Salas; Han Moshage
Journal:  Antioxidants (Basel)       Date:  2022-05-16

2.  Screening Potential Drugs for the Development of NAFLD Based on Drug Perturbation Gene Set.

Authors:  Zhengzheng Gao; Lina Dai; Haifeng Zhang
Journal:  Comput Math Methods Med       Date:  2022-04-16       Impact factor: 2.809

3.  YAP1 alleviates sepsis-induced acute lung injury via inhibiting ferritinophagy-mediated ferroptosis.

Authors:  Jing Zhang; Yongping Zheng; Yun Wang; Jin Wang; Aming Sang; Xuemin Song; Xinyi Li
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

4.  YAP1 protects against septic liver injury via ferroptosis resistance.

Authors:  Jin Wang; Qian Zhu; Rui Li; Jing Zhang; Xujun Ye; Xinyi Li
Journal:  Cell Biosci       Date:  2022-10-01       Impact factor: 9.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.